Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Can Data Management Tools Improve Research Efficiency and Reproducibility?
Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...
How Do Fats Help Us Treat Brain Cancer?
Malignant Brain Tumors will kill over 13,000 cancer patients this year in the United States alone; brain tumors...
Can we use our immune cells to fight lung disease?
Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...